Showing results (301-310 of 571) with videos related to
Sort By:
Pageof 58
Clinical Breast Cancer|February 6, 2010
Clinical outcomes of patients with breast cancer in a phase I clinic: the M. D. Anderson cancer center experienceJennifer Wheler, Apostolia M Tsimberidou, Stacy Moulder, et al.Investigational New Drugs|October 1, 2016
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experienceManojkumar Bupathi, Joud Hajjar, Stacie Bean, et al.JAMA Oncology|September 19, 2019
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal CancerDawei Chen, Hari Menon, Vivek Verma, et al.The Lancet. Respiratory Medicine|October 23, 2020
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trialsWillemijn S M E Theelen, Dawei Chen, Vivek Verma, et al.Frontiers in Immunology|November 21, 2022
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer modelYun Hu, Sébastien Paris, Genevieve Bertolet, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2024
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinomaKelsey L Corrigan, Ting Xu, Yuki Sasaki, et al.American Journal of Medical Genetics. Part A|February 15, 2025
Research Priorities of Individuals and Families With Sex Chromosome AneuploidiesAlexandra Carl, Samantha Bothwell, Fathia Farah, et al.Cancer Chemotherapy and Pharmacology|October 14, 2010
Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvementApostolia M Tsimberidou, Katherine Letourneau, Siqing Fu, et al.Clinical Epigenetics|July 16, 2014
Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samplesDavid J Stewart, Maria I Nunez, Jaroslav Jelinek, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2012
Advance care planning in patients with cancer referred to a phase I clinical trials program: the MD Anderson Cancer Center experienceSiqing Fu, F Diane Barber, Aung Naing, et al.Pageof 58